Overview:

We study the landscape of product innovation in the pharmaceutical sector (drugs and medical devices) that is heavily regulated by the Food and Drug Administration (FDA). The non-traditional data sources include publicly available opportunity and administrative data such as drug approvals and listings as well as news articles obtained from Dow Jones, a business news and data provider. We implement natural language processing methods and fuzzy matching techniques to identify innovators and use our findings to study how innovators might participate in the product development pipeline as reflected by these novel data sources.

Teaser Video:

Research Project Webpage:

Click here for more details about the project including findings, data, and methods.

Fellows:

Susweta Ray

Susweta Ray

University of Nebraska-Lincoln, PhD in Agricultural Economics, Statistics
 
 
 
 

Interns:

Isabel Gomez

Isabel Gomez

Smith College, Statistical and Data Science
 
 
 
 

Ian MacLeod

Ian MacLeod

The University of Mary Washington, Computer Science
 
 
 
 

Mentors:

Gizem Korkmaz

Research Associate Professor, Biocomplexity Institute, University of Virginia

Devika Mahoney-Nair

Research Scientist, Biocomplexity Institute, University of Virginia

Neil Alexander Kattampallil

Research Scientist, Biocomplexity Institute, University of Virginia

Stakeholder:

Gary Anderson, Senior Science Resources Analyst, National Center for Science and Engineering Statistics, Research & Development Statistics Program